Market closedADR
Novartis/$NVS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Novartis
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Ticker
$NVS
Sector
Health Care
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Basel, Switzerland
Employees
76,057
Website
Novartis Metrics
BasicAdvanced
$236B
14.95
$7.84
0.49
$2.43
2.07%
Price and volume
Market cap
$236B
Beta
0.49
52-week high
$120.06
52-week low
$92.19
Average daily volume
985K
Dividend rate
$2.43
Financial strength
Current ratio
0.931
Quick ratio
0.612
Long term debt to equity
50.649
Total debt to equity
69.178
Dividend payout ratio (TTM)
47.13%
Interest coverage (TTM)
16.31%
Management effectiveness
Return on assets (TTM)
8.86%
Return on equity (TTM)
21.50%
Valuation
Price to earnings (TTM)
14.953
Price to revenue (TTM)
4.91
Price to book
4.9
Price to tangible book (TTM)
-18.13
Price to free cash flow (TTM)
17.692
Dividend yield (TTM)
2.07%
Forward dividend yield
2.07%
Growth
Revenue change (TTM)
9.70%
Earnings per share change (TTM)
118.29%
3-year revenue growth (CAGR)
-1.77%
3-year earnings per share growth (CAGR)
25.68%
3-year dividend per share growth (CAGR)
4.94%
What the Analysts think about Novartis
Analyst Ratings
Majority rating from 11 analysts.
Novartis Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$12B
2.92%
Net income
$2.7B
-68.30%
Profit margin
22.17%
-69.21%
Novartis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.83
$1.83
$1.53
$1.80
-
Expected
$1.68
$1.70
$1.69
$1.69
$1.86
Surprise
8.68%
7.86%
9.20%
6.76%
-
Novartis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closedADR
Upcoming events
Apr25
Novartis
Dividend·Payment
$3.99399
Per share
FAQs
What’s the current market cap for Novartis stock?
Novartis (NVS) has a market cap of $236B as of April 24, 2025.
What is the P/E ratio for Novartis stock?
The price to earnings (P/E) ratio for Novartis (NVS) stock is 14.95 as of April 24, 2025.
Does Novartis stock pay dividends?
Yes, the Novartis (NVS) stock pays dividends to shareholders. As of April 24, 2025, the dividend rate is $2.4307 and the yield is 2.07%. Novartis has a payout ratio of 47.13% on a trailing twelve-month basis.
When is the next Novartis dividend payment date?
The next Novartis (NVS) dividend payment is scheduled for April 25, 2025.
What is the beta indicator for Novartis?
Novartis (NVS) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.